The
Clinical Research Services Group of Reliance Life Sciences is
building a global business that provides
world-class product development services
to pharmaceutical, biotechnology and medical
device companies. Headquartered in India,
the Clinical Research Services Group also
has offices in Europe. The Phase I and
Bioavailability - Bioequivalence clinics
are located in Navi Mumbai and Bangalore,
India.
Reliance Life Sciences offers a comprehensive range of services covering:
- Regulatory Toxicity Studies
- Bioavailability - Bioequivalence (BA
/ BE) Studies
- Pharmacokinetics
- Cardiac Safety
- Mass Balance Studies
- Phase I to IV Clinical Trial Management
and Monitoring
- Data management and Biostatistics
- Medical Writing
Reliance Life Sciences has extensive experience across various therapeutic domains. Key among these are:
- Infectious diseases
- Oncology
- Vaccines
- Cardiovascular diseases
- Immunology
- Dermatology
- Psychiatry
- Gynaecology
- Endocrinology
- Haemotology
- Gastroentology
- Orthopaedics
- Virology
- Neurology
- Nephrology
- Cardiovascular
- Ophthalmology
All
the clinical research studies are conducted
in strict compliance with ICH-GCP guidelines
and applicable Indian laws governing clinical
research.
The pathology laboratory is accredited by
the College of American Pathologists (CAP)
and the National Accreditation Board for
Laboratories (NABL), India. The Bioavailability/Bioequivalence
centre has successfully done studies meeting
the requirements of Indian Regulatory Authorities,
US FDA, MHRA (UK), ANVISA Brazil, MPA (Sweden)
and MOH (Turkey).
Animal House
Reliance Life Sciences has established a
state-of-the-art, barrier-maintained animal
facility for breeding and experimentation
on small animals to meet internal, as well
as client needs.
The facility breeds and maintains animals
in individual ventilated cages (IVC) and
conforms to the guidelines outlined by the
Committee for the Purpose of Control and
Supervision of Experiments on Animals (CPCSEA).
It is the only facility in India designed
to carry out experiments on immuno-compromised
animals in a class 10,000 facility.
Clinical Pharmacology
Reliance
Life Sciences operates a three-clinic, 100-bed
state-of-the-art clinical facility in Navi
Mumbai, India and in Bangalore, India with
4 clinics for BA / BE studies, including
facilities for studies on female volunteers.
Additionally, Reliance Life Sciences also
operates an 11-bed ICU facility for Phase
I studies, with a complete cardiac monitoring
and recording facility in Navi Mumbai. These
facilities are supported by in-house pathology
and bioanalytical facilities.
For more information please visit the website
of Reliance Clinical Research Services at
www.relclin.com
To know more about Clinical Research Services,
click
here
